Inventor · disambiguated record
Jong Ik Hwang
Also filed as: HWANG JONG IK
11 granted patents·5 pending applications·58 citations·filing 2010–2025
88Inventor score
Top patents by PatentIndex Score
16 records- 0196US11739141B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2020·Granted Aug 29, 2023·7 cites·16 claims
- 0294US11332521B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2017·Granted May 17, 2022·12 cites·20 claims
- 0394US10640557B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2017·Granted May 5, 2020·11 cites·18 claims
- 0493US9579398B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2013·Granted Feb 28, 2017·22 cites·24 claims
- 0585US12435130B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2023·Granted Oct 7, 2025·0 cites·15 claims
- 0684US2025236663A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 0778US12202889B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2022·Granted Jan 21, 2025·0 cites·16 claims
- 0878US10385098B2Agonist of spexin-based galanin type 2 receptor and use thereofNEURACLE SCIENCE CO LTD·Filed 2016·Granted Aug 20, 2019·3 cites·20 claims
- 0975US2025263479A1Pharmaceutical use of fam19a5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 1071US11248023B2Agonist of spexin-based galanin type 2 receptor and use thereofNEURACLE SCIENCE CO LTD·Filed 2019·Granted Feb 15, 2022·1 cites·20 claims
- 1171US2025353902A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 1267US9018439B2Transgenic pig in which HO-1 and TNFR1-Fc are simultaneously expressed, and method for producing sameAHN CURIE·Filed 2010·Granted Apr 28, 2015·2 cites·17 claims
- 1365US2022242910A1Agonist of spexin-based galanin type 2 receptor and use thereofNEURACLE SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 1452US2023104540A1Use of anti-fam19a1 antagonists for treating central nervous system diseasesNEURACLE SCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 1546US9357754B2Transgenic pig expressing sTNFR1-Fc genes and the uses thereofAHN CURIE·Filed 2012·Granted Jun 7, 2016·0 cites·15 claims
- 1638US9556242B2Method for regulating circadian rhythmsSEONG JAE-YOUNG·Filed 2012·Granted Jan 31, 2017·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Jong Ik Hwang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →